APPISTADIUM
0731.917.359 · rovalta.com · 23/09/2026
APPISTADIUM
Company — Normal situation.
Overview
What does APPISTADIUM do?
APPISTADIUM is a company registered in Belgium.
Joint committees (1)
- 200
Trend over 5 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 219,6 k € | +85.7% | 118,3 k € | +193% | -127,3 k € | -52.6% | -83,4 k € | -37.4% | -60,7 k € |
| EBITDA | 213,1 k € | +1159% | 16,9 k € | +108% | -219,7 k € | -11.0% | -198 k € | -129% | -86,5 k € |
| Operating result | 149,8 k € | +436% | -44,6 k € | +82.5% | -254,2 k € | -18.4% | -214,7 k € | -108% | -103,2 k € |
| Net result | 149,3 k € | +390% | -51,5 k € | +80.5% | -263,7 k € | -19.8% | -220 k € | -107% | -106,4 k € |
| Balance sheet | |||||||||
| Equity | 72,7 k € | +195% | -76,6 k € | -205% | -25,1 k € | +91.9% | -311,5 k € | -241% | -91,4 k € |
| Total assets | 189,4 k € | -16.6% | 227,2 k € | -23.2% | 295,9 k € | +289% | 76 k € | +45.0% | 52,4 k € |
| Cash | 5,2 k € | – | 51,1 k € | – | 276,7 € | ||||
| Debts | 116,7 k € | -61.5% | 302,9 k € | -5.3% | 319,9 k € | -17.2% | 386,4 k € | +169% | 143,9 k € |
Board of directors
Seen on filing of 31/12/2024 · 1 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 05/08/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 17 months |
| Filing date | 15/05/2025 | 02/11/2024 | 02/10/2023 | 29/08/2022 | 26/08/2021 |
| General meeting | 08/05/2025 | 31/10/2024 | 26/09/2023 | 31/07/2022 | 24/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
5 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 08/05/2025 | 15/05/2025 | French | |
| Micro model | 31/12/2023 | 31/10/2024 | 02/11/2024 | French | |
| Micro model | 31/12/2022 | 26/09/2023 | 02/10/2023 | French | |
| Micro model | 31/12/2021 | 31/07/2022 | 29/08/2022 | French | |
| Micro model | 31/12/2020 | 24/06/2021 | 26/08/2021 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2024 · 1 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024149,3 k €↑
- 2023Annual accounts 2023-51,5 k €↑
- 2022Annual accounts 2022-263,7 k €↓
- 2022Name changeAPPISTADIUM
- 2021Annual accounts 2021-220 k €↓
- 2021Name changeAPPIMONKEY
- 2020Annual accounts 2020-106,4 k €